{"nctId":"NCT05403827","briefTitle":"A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease","startDateStruct":{"date":"2022-07-03","type":"ACTUAL"},"conditions":["Dry Eye Disease"],"count":644,"armGroups":[{"label":"K-161","type":"EXPERIMENTAL","interventionNames":["Drug: K-161"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"K-161","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Be at least 18 years of age at the time of Informed Consent\n* Have a reported history of dry eye disease in both eyes and a history of eye drop use for dry eye symptom\n* Meet all other inclusion criteria outlined in the clinical study protocol\n\nExclusion Criteria:\n\n* Have any clinically significant ocular condition\n* Have a history of corneal refractive surgery and/or any other ocular surgical procedure within 12 months\n* Meet any other exclusion criteria outlined in the clinical study protocol","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in EDS (VAS) From Baseline to Day 85","description":"* Eye Dryness Score (EDS) on Visual analog scale (VAS)\n* Participant self rated level of severity where, 0 mm corresponds to \"None\" and 100 mm corresponds to \"Worst Possible\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.0","spread":"25.10"},{"groupId":"OG001","value":"-19.4","spread":"25.34"}]}]}]},{"type":"PRIMARY","title":"Change in Conjunctival Sum Fluorescein Staining Score From Baseline to Day 85 (Study Eye)","description":"* Assessed by expanded National Eye Institute (NEI) scale\n* Conjunctival sum will be assessed as the sum of points in 6 conjunctival zones, and each zone will be graded on a 5-point scale from 0 - no conjunctival staining to 4 - severe staining of the area (0.5 increments would be allowed)\n* Minimum is 0 and maximum is 24 for Conjunctival Sum Fluorescein Staining Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.81","spread":"3.661"},{"groupId":"OG001","value":"-3.25","spread":"3.480"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Day 85 in Total Eye Sum Fluorescein Staining Score (Study Eye)","description":"* Assessed by expanded National Eye Institute (NEI) scale.\n* Total eye sum will be assessed as the sum of Corneal sum fluorescein staining score and conjunctival sum fluorescein staining score.\n* Minimum is 0 and maximum is 44 for Total Eye Sum Fluorescein Staining Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.73","spread":"5.693"},{"groupId":"OG001","value":"-5.44","spread":"5.546"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Day 85 in Corneal Sum Fluorescein Staining Score (Study Eye)","description":"* Assessed by expanded National Eye Institute (NEI) scale.\n* Corneal sum will be assessed as the sum of points in 5 corneal zones, and each zone will be graded on a 5-point scale from 0 - no punctate stain in the area to 4 - Severe diffuse (coalescent) macropunctate stain of the area (0.5 increments would be allowed)\n* Minimum is 0 and maximum is 20 for Corneal Sum Fluorescein Staining Score","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.92","spread":"2.905"},{"groupId":"OG001","value":"-2.19","spread":"2.841"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Day 85 in Ocular Surface Disease Index Score (OSDIÂ©)","description":"OSDI is assessed on a scale of 0 to 100, with higher scores representing greater disability.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.12","spread":"17.099"},{"groupId":"OG001","value":"-14.17","spread":"17.594"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Day 85 in Schirmer's Test (Unanesthetized) (Study Eye)","description":"Length (mm) of the moistened area assessed by inserting a Schirmer test strip into the eye for 5 minutes to measure the production of tears.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"5.47"},{"groupId":"OG001","value":"2.6","spread":"5.25"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline to Day 85 in Tear Film Break-up Time (TFBUT) (Study Eye)","description":"The time (in seconds) taken for the first dry spot to appear on the cornea after a complete blink (with the aid of a slit-lamp).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.580","spread":"1.2089"},{"groupId":"OG001","value":"0.520","spread":"1.1989"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":321},"commonTop":["Instillation site pain"]}}}